University of Manitoba researchers launch clinical trial for Alzheimer’s
WINNIPEG — A team of researchers from the University of Manitoba is testing an experimental treatment for Alzheimer’s disease.
The clinical trial is being led by Dr. Zahara Moussavi and will test the effects of magnetic fields on the brains of early stage dementia patients.
The Weston Brain Institute has announced $1.7 million for Moussavi’s research.
The clinical trial will be run out of the Riverview Health Centre in Winnipeg, where Moussavi has her lab, as well as sites in Montreal and Australia.